Skip to main content
Premium Trial:

Request an Annual Quote

Czech, Slovak Cancer Study to Use AdnaGen Assay

NEW YORK (GenomeWeb News) – Scientists in the Czech Republic and Slovakia will use a breast cancer test from OncoVista Innovative Therapies subsidiary AdnaGen in a cancer research effort focused on using the predictive assay in clinics, the San Antonio-based firm said today.

Under the agreement, Tataa Molecular Diagnostics will partner with the Institute of Biotechnology of the Czech Academy of Science on the COHERTA study, which is funded in part through a grant from Hoffman-La Roche's Czech and Slovak subsidiaries.

The three-year COHERTA study will use the Adnatest BreastCancer assay to evaluate the relationship between HER2 status of metastatic tumors and of circulating tumor cells.

HER2 status is a marker for disease prognosis and therapy, and it may change as disease progresses. Today, the only way to evaluate the HER2 status of a tumor is through a tissue biopsy of the tumor, said OncoVista.

OncoVista President and CEO Alexander Weis said in a statement that assays like Adnatest could "lead to better evaluation sooner and more cost-effective treatments with less unnecessary suffering and toxic side-effects."

Financial terms of the agreement were not released.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.